Search Results

Below are the search engine results of your query.

Showing 971-980 of 3090 results

Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million

The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it completed the sale of its Glycolic Acid Business to PureTech Scientific, LLC, a company founded and backed by Iron Path Capital, a private equity firm focused on lower-middle market inv...

Chemical Industry Announces Collaborative Equity, Diversity & Inclusion STEM Scholars Initiative

The American Chemistry Council (ACC), American Institute of Chemical Engineers (AIChE), The Chemours Company and HBCU Week Foundation today announced the chemical industry's first collaborative equity, diversity and inclusion initiative aimed at creating pathways for more underrepresented groups to enter and succeed in the chemical industry.

Chemours Announces Third Quarter Dividend

The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the company's common stock for the third quarter of 2020.

The Chemours Company Announces Completion of Private Offering of $800 Million Aggregate Principal Amount of 5.750% Senior Unsecured Notes Due 2028

The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced it had completed its previously announced private offering (the "offering") of $800 million in aggregate principal amount of 5.750% senior unsecured notes due 2028 that was exempt from the registration requirements o...

U.S. Environmental Protection Agency Approves Glyclean™ Hard Surface Cleaner as an Effective Disinfectant Against the Virus that Causes COVID-19

Hard surface disinfectant formulations with Glyclean™AM as the active ingredient effectively kill SARS-CoV-2, the virus that causes COVID-19.

The Chemours Company Reports Third Quarter 2020 Results

Quarter Reflects Disciplined Execution with Strong Free Cash Flow and Solid Financial Results The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced its financial results for the third quarter 2020.

The Chemours Company Reports Second Quarter 2020 Results

Strong Improvement in Free Cash Flow Despite Weak Global Demand; COVID-19 Response Plan Remains on Track  The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced its financial results for the second quarter 2020.

The Chemours Company Reports Fourth Quarter and Full Year 2019 Results

Full Year 2019 Results In-line with Updated Guidance Full Year 2019 Results Net Sales of $5.5 billion Net Income of $(52) million with EPS of $(0.32) Adjusted Net Income of $419 million with Adjusted EPS of $2.51 Adjusted EBITDA of $1.02 billion Free Cash Flow of $169 million Returned $486 million to shareholders through share repurchases and dividends Fourth Quarter 2019 Results Net Sales of $1.4...

The Chemours Company Provides COVID-19 Update

Out of an abundance of caution, borrows $300M under $800M revolving credit facility The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced action it is taking to address macroeconomic uncertainty driven by the coronavirus (COVID-19).

The Chemours Company Announces Conditional Redemption And Cash Tender Offer And Consent Solicitation For Any And All Of Its 6.625% Senior Notes Maturing In 2023

The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced that it has commenced a tender offer (the "Tender Offer") to purchase for cash any and all of its outstanding 6.625% senior notes due 2023 (the "Notes").